Bruker Corporation (BRKR) 22.44 $BRKR
Research Reports Initiation on Medical Laboratories & Research Stocks -- Quest Diagnostics, Bruker, Organovo, and Alere
PR Newswire - Wed Aug 31, 7:00AM CDT
Stock-Callers.com draws investors' attention to these Medical Laboratories and Research equities: Quest Diagnostics Inc. (NYSE: DGX), Bruker Corp. (NASDAQ: BRKR), Organovo Holdings Inc. (NASDAQ: ONVO), and Alere Inc. (NYSE: ALR). Industry growth is influenced by a number of trends, which include demographics, emerging economies, biotech advances in genetics, and pathogen evolution. Learn more about these stocks by downloading their free report at: http://stock-callers.com/registration
ONVO: 3.79 (-0.07), DGX: 82.36 (-0.46), BRKR: 22.44 (+0.08), ALR: 38.44 (-0.69)
Bruker Corporation to Present at Investor Conferences
PR Newswire - Wed Aug 31, 6:00AM CDT
Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences:
BRKR: 22.44 (+0.08), WFC: 50.43 (-0.37)
Short Interest In Bruker Declines 17%
MarketNewsVideo.com - Thu Aug 25, 2:29PM CDT
The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 751,751 share decrease in total short interest for Bruker Corp , to 3,678,038, a decrease of 16.97% since 07/29/2016. Total short interest is...
BRKR: 22.44 (+0.08)
Bruker's Q2 Results Disappoint, Product Launches Continue
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:14AM CDT
On Aug 12, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), BRKR: 22.44 (+0.08), NUVA: 66.06 (+0.59)
FlavorActiV and Bruker Announce Flavor Stability Partnership at World Brewing Congress
PR Newswire - Mon Aug 15, 8:30AM CDT
At the World Brewing Congress (www.worldbrewingcongress.org) in Denver, USA, FlavorActiV and Bruker Corporation (NASDAQ: BRKR) announced their strategic partnership and the launch of the Flavor Stability Package, by combining world-class beer sensory know-how with consistent tools and proven Bruker e-scan(TM) EPR technology.
BRKR: 22.44 (+0.08)
Bruker Announces Quarterly Dividend
PR Newswire - Tue Aug 09, 6:00AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on September 23, 2016 to stockholders of record as of September 6, 2016.
BRKR: 22.44 (+0.08)
Bruker (BRKR) Posts In-Line Q2 Earnings, Misses Sales
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 7:29AM CDT
Bruker's (BRKR) second quarter earnings came in line with the Zacks Consensus Estimate, while revenues missed the mark.
BABY: 39.71 (+0.80), MASI: 59.43 (+0.29), BRKR: 22.44 (+0.08), IDXX: 113.16 (+0.48)
Downgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Thu Aug 04, 3:52AM CDT
Bruker (NASDAQ:BRKR) was downgraded from Outperform to Market Perform at Wells Fargo today. The stock closed yesterday at $21.79 on volume of 4.6 million shares, above average daily volume of 1.1 million. Bruker share prices have moved between a 52-week high of $29.85 and a 52-week low of $15.78 and closed yesterday at 38% above that low price at $21.79 per share. The 200-day and 50-day moving averages have moved 0.62% higher and 0.71% higher over the past week, respectively.
BRKR: 22.44 (+0.08)
Upgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Thu Aug 04, 3:50AM CDT
Bruker (NASDAQ:BRKR) was upgraded from Neutral to Buy at Janney Montgomery today. The stock closed yesterday at $21.79 on volume of 4.6 million shares, above average daily volume of 1.1 million. There is potential upside of 2.0% for shares of Bruker based on a current price of $21.79 and an average consensus analyst price target of $22.23. The stock should find initial resistance at its 200-day moving average (MA) of $22.60 and further resistance at its 50-day MA of $28.13.
BRKR: 22.44 (+0.08)
SmarTrend Watching for Potential Rebound in Shares of Bruker After 12.06% Loss
Comtex SmarTrend(R) - Wed Aug 03, 1:56PM CDT
Bruker (NASDAQ:BRKR) traded in a range yesterday that spanned from a low of $21.38 to a high of $22.93. Yesterday, the shares fell 12.1%, which took the trading range below the 3-day low of $24.31 on volume of 2.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BRKR: 22.44 (+0.08)
Bruker Reports Second Quarter 2016 Financial Results
PR Newswire - Tue Aug 02, 3:05PM CDT
Bruker Corporation (NASDAQ: BRKR) today reported financial results for its second quarter ended June 30, 2016.
BRKR: 22.44 (+0.08)
Bruker Acquires Software Assets for Next-Generation Automated and Quantitative Mineral Identification and Characterization
PR Newswire - Mon Jun 20, 6:00AM CDT
Bruker today announced that it has acquired the assets of Yingsheng Technology Pty Ltd. in Brisbane, Australia, that relate to the 3rd generation Advanced Mineral Identification and Characterization System (AMICS) software package, and respective IP for advanced minerals identification and characterization.
BRKR: 22.44 (+0.08)
Bruker Collaborates with CDC to Advance Infectious Disease Surveillance
PR Newswire - Thu Jun 16, 6:00AM CDT
At the American Society for Microbiology (ASM) Microbe 2016 conference, Bruker today announces the results of a successful collaboration with the Special Bacteriology Reference Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia to create an expanded microorganism reference library for the Bruker MALDI Biotyper.
BRKR: 22.44 (+0.08)
Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 125.21 (+0.44), LMAT: 17.76 (-0.62), BRKR: 22.44 (+0.08), NUVA: 66.06 (+0.59)
Short Interest In Bruker Expands By 15.4%
MarketNewsVideo.com - Fri Jun 10, 1:31PM CDT
The most recent short interest data has been released for the 05/31/2016 settlement date, which shows a 764,514 share increase in total short interest for Bruker Corp , to 5,717,406, an increase of 15.44% since 05/13/2016. Total short interest is...
BRKR: 22.44 (+0.08)
Bruker Shows Innovative rapifleX MALDI-TOF/TOF at ASMS 2016
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces rapifleX(TM), the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX is by far the most advanced TOF/TOF system today, and was re-designed from the ground up to meet today's highest demands for in-depth intact and top-down protein characterization, and high-performance, high-throughput mass spectrometry imaging (MSI).
BRKR: 22.44 (+0.08)
Bruker Launches rapifleX MALDI PharmaPulse Solution for uHTS
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX(TM) MALDI PharmaPulse(TM) (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
BRKR: 22.44 (+0.08)
Bruker Introduces Innovative timsTOF(TM) Mass Spectrometer
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF(TM) system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
BRKR: 22.44 (+0.08)
Why These Stocks are Under the Investor Community's Microscope? - Bruker, Quintiles Transnational Holdings, iKang Healthcare Group, and TrovaGene
PR Newswire - Wed Jun 01, 7:20AM CDT
In today's pre-market research, ActiveWallSt.com has selected the following Medical Laboratories and Research stocks for your evaluation: Bruker Corp. (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), iKang Healthcare Group Inc. (NASDAQ: KANG), and TrovaGene Inc. (NASDAQ: TROV). Access these equities free technical alerts at:
Q: 77.42 (+0.12), TROV: 4.96 (+0.05), KANG: 18.22 (-0.22), BRKR: 22.44 (+0.08)
Dr. Cynthia Friend Joins Bruker Board of Directors
PR Newswire - Mon May 23, 9:46AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its shareholders have elected Dr. Cynthia Friend as a new member of the Board of Directors, effective May 20, 2016.
BRKR: 22.44 (+0.08)
Research Reports Initiation on Medical Laboratories & Research Stocks -- Quest Diagnostics, Bruker, Organovo, and Alere
PR Newswire - Wed Aug 31, 7:00AM CDT
Stock-Callers.com draws investors' attention to these Medical Laboratories and Research equities: Quest Diagnostics Inc. (NYSE: DGX), Bruker Corp. (NASDAQ: BRKR), Organovo Holdings Inc. (NASDAQ: ONVO), and Alere Inc. (NYSE: ALR). Industry growth is influenced by a number of trends, which include demographics, emerging economies, biotech advances in genetics, and pathogen evolution. Learn more about these stocks by downloading their free report at: http://stock-callers.com/registration
ONVO: 3.79 (-0.07), DGX: 82.36 (-0.46), BRKR: 22.44 (+0.08), ALR: 38.44 (-0.69)
Bruker Corporation to Present at Investor Conferences
PR Newswire - Wed Aug 31, 6:00AM CDT
Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences:
BRKR: 22.44 (+0.08), WFC: 50.43 (-0.37)
Short Interest In Bruker Declines 17%
MarketNewsVideo.com - Thu Aug 25, 2:29PM CDT
The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 751,751 share decrease in total short interest for Bruker Corp , to 3,678,038, a decrease of 16.97% since 07/29/2016. Total short interest is...
BRKR: 22.44 (+0.08)
Bruker's Q2 Results Disappoint, Product Launches Continue
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:14AM CDT
On Aug 12, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
GWPH: 82.28 (+0.53), QDEL: 21.74 (-0.03), BRKR: 22.44 (+0.08), NUVA: 66.06 (+0.59)
FlavorActiV and Bruker Announce Flavor Stability Partnership at World Brewing Congress
PR Newswire - Mon Aug 15, 8:30AM CDT
At the World Brewing Congress (www.worldbrewingcongress.org) in Denver, USA, FlavorActiV and Bruker Corporation (NASDAQ: BRKR) announced their strategic partnership and the launch of the Flavor Stability Package, by combining world-class beer sensory know-how with consistent tools and proven Bruker e-scan(TM) EPR technology.
BRKR: 22.44 (+0.08)
Bruker Announces Quarterly Dividend
PR Newswire - Tue Aug 09, 6:00AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on September 23, 2016 to stockholders of record as of September 6, 2016.
BRKR: 22.44 (+0.08)
Bruker (BRKR) Posts In-Line Q2 Earnings, Misses Sales
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 7:29AM CDT
Bruker's (BRKR) second quarter earnings came in line with the Zacks Consensus Estimate, while revenues missed the mark.
BABY: 39.71 (+0.80), MASI: 59.43 (+0.29), BRKR: 22.44 (+0.08), IDXX: 113.16 (+0.48)
Downgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Thu Aug 04, 3:52AM CDT
Bruker (NASDAQ:BRKR) was downgraded from Outperform to Market Perform at Wells Fargo today. The stock closed yesterday at $21.79 on volume of 4.6 million shares, above average daily volume of 1.1 million. Bruker share prices have moved between a 52-week high of $29.85 and a 52-week low of $15.78 and closed yesterday at 38% above that low price at $21.79 per share. The 200-day and 50-day moving averages have moved 0.62% higher and 0.71% higher over the past week, respectively.
BRKR: 22.44 (+0.08)
Upgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Thu Aug 04, 3:50AM CDT
Bruker (NASDAQ:BRKR) was upgraded from Neutral to Buy at Janney Montgomery today. The stock closed yesterday at $21.79 on volume of 4.6 million shares, above average daily volume of 1.1 million. There is potential upside of 2.0% for shares of Bruker based on a current price of $21.79 and an average consensus analyst price target of $22.23. The stock should find initial resistance at its 200-day moving average (MA) of $22.60 and further resistance at its 50-day MA of $28.13.
BRKR: 22.44 (+0.08)
SmarTrend Watching for Potential Rebound in Shares of Bruker After 12.06% Loss
Comtex SmarTrend(R) - Wed Aug 03, 1:56PM CDT
Bruker (NASDAQ:BRKR) traded in a range yesterday that spanned from a low of $21.38 to a high of $22.93. Yesterday, the shares fell 12.1%, which took the trading range below the 3-day low of $24.31 on volume of 2.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BRKR: 22.44 (+0.08)
Bruker Reports Second Quarter 2016 Financial Results
PR Newswire - Tue Aug 02, 3:05PM CDT
Bruker Corporation (NASDAQ: BRKR) today reported financial results for its second quarter ended June 30, 2016.
BRKR: 22.44 (+0.08)
Bruker Acquires Software Assets for Next-Generation Automated and Quantitative Mineral Identification and Characterization
PR Newswire - Mon Jun 20, 6:00AM CDT
Bruker today announced that it has acquired the assets of Yingsheng Technology Pty Ltd. in Brisbane, Australia, that relate to the 3rd generation Advanced Mineral Identification and Characterization System (AMICS) software package, and respective IP for advanced minerals identification and characterization.
BRKR: 22.44 (+0.08)
Bruker Collaborates with CDC to Advance Infectious Disease Surveillance
PR Newswire - Thu Jun 16, 6:00AM CDT
At the American Society for Microbiology (ASM) Microbe 2016 conference, Bruker today announces the results of a successful collaboration with the Special Bacteriology Reference Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia to create an expanded microorganism reference library for the Bruker MALDI Biotyper.
BRKR: 22.44 (+0.08)
Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 125.21 (+0.44), LMAT: 17.76 (-0.62), BRKR: 22.44 (+0.08), NUVA: 66.06 (+0.59)
Short Interest In Bruker Expands By 15.4%
MarketNewsVideo.com - Fri Jun 10, 1:31PM CDT
The most recent short interest data has been released for the 05/31/2016 settlement date, which shows a 764,514 share increase in total short interest for Bruker Corp , to 5,717,406, an increase of 15.44% since 05/13/2016. Total short interest is...
BRKR: 22.44 (+0.08)
Bruker Shows Innovative rapifleX MALDI-TOF/TOF at ASMS 2016
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces rapifleX(TM), the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX is by far the most advanced TOF/TOF system today, and was re-designed from the ground up to meet today's highest demands for in-depth intact and top-down protein characterization, and high-performance, high-throughput mass spectrometry imaging (MSI).
BRKR: 22.44 (+0.08)
Bruker Launches rapifleX MALDI PharmaPulse Solution for uHTS
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX(TM) MALDI PharmaPulse(TM) (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
BRKR: 22.44 (+0.08)
Bruker Introduces Innovative timsTOF(TM) Mass Spectrometer
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF(TM) system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
BRKR: 22.44 (+0.08)
Why These Stocks are Under the Investor Community's Microscope? - Bruker, Quintiles Transnational Holdings, iKang Healthcare Group, and TrovaGene
PR Newswire - Wed Jun 01, 7:20AM CDT
In today's pre-market research, ActiveWallSt.com has selected the following Medical Laboratories and Research stocks for your evaluation: Bruker Corp. (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), iKang Healthcare Group Inc. (NASDAQ: KANG), and TrovaGene Inc. (NASDAQ: TROV). Access these equities free technical alerts at:
Q: 77.42 (+0.12), TROV: 4.96 (+0.05), KANG: 18.22 (-0.22), BRKR: 22.44 (+0.08)
Dr. Cynthia Friend Joins Bruker Board of Directors
PR Newswire - Mon May 23, 9:46AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its shareholders have elected Dr. Cynthia Friend as a new member of the Board of Directors, effective May 20, 2016.
BRKR: 22.44 (+0.08)
